Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 CAD | -5.16% | -9.82% | -56.12% |
May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
Evolution of the average Target Price on Aptose Biosciences Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Aptose Biosciences Inc.
RBC Capital Markets | |
HC Wainwright | |
Oppenheimer | |
Piper Sandler | |
Canaccord Genuity |
EPS Revisions
- Stock Market
- Equities
- APS Stock
- Consensus Aptose Biosciences Inc.